The precise aetiology of diabetes mellitus remains unknown. There is clearly both a genetic element which is almost certainly multifactorial, due to the multiple and additive effects of genes especially in younger patients, together with environmental factors, especially in older patients.
I T is almost 50 years since the discovery of insulin by Banting and Best in 1921 and the demonstration of its effectiveness in reversing at least the acute metabolic disturbances of the diabetic syndrome. Although, as a result of intensive pharmacological and biochemical study in the intervening years, enormous insight has been gained into the metabolism of insulin, the essential defect of diabetes mellitus remains unknown as does also the pathogenesis of the seemingly inevitable long term vascular complications.
This review, which of necessity is brief and incomplete, attempts to summarize the present understanding of the pathogenesis of diabetes mellitus, and needs to take into consideration the many factors that are now known to regulate or modify the release of insulin from the islets and influence its effectiveness in the peripheral tissues. HEREDITY Several studies of the familial aggregation of diabetes mellitus and the high concordance rate in monozygotic twins which approaches unity leave little doubt that genetic transmission plays a major role in both juvenile and adult-onset diabetes. The exact mode of transmission, however, has not yet been established with any degree of certainty.
The genetic study of diabetes has been termed a 'geneticist's nightmare' (Neel, 1969) , and major difficulties lie in the lack of precise knowledge of the basic defect(s) which is probably not the same in all patients, the debatable diagnostic criteria, the variability of the clinical features such as age of onset and severity, and the finding of abnormalities of carbohydrate tolerance and insulin secretory response to glucose in close relatives in whom the disease never becomes manifest. Various modes of inheritance have been advanced to explain the observed facts and are reviewed by Clarke and Thompson (1970) .
Reappraisal of previously published data make the traditional single gene hypothesis, such as simple recessive inheritance with reduced penetrance (Steinberg, 1959) , unlikely and this has been mainly abandoned in favour of an hypothesis of multifactorial inheritance. Neel (1969) and others have 3 main arguments, none by itself really convincing, in favour of a more complex mode of inheritance. Firstly, it is now known from the physiological viewpoint that the primary failure of insulin production or its effectiveness can result from disturbance of a number of different functions; secondly, data from first degree relatives of diabetic subjects tested for carbohydrate tolerance, though showing skewness to the right compared with unselected populations, reveal no evidence of bimodality or trimodality as would be expected in a monogenetic trait; and thirdly, data from the offsprings of conjugal diabetics infers that there are a number of different kinds of recessivelyinherited diabetes, whereas if this was due to homozygosity for a recessive gene occurring at a single locus all offsprings should be affected.
Multifactorial inheritance implies the small additive effects of several alleles at different chromosomal loci, the precise combination (genotypes) of which may vary from one diabetic to the next, with or without environmental influences. The hypothesis would make several data more explicable, especially the differences between juvenile onset forms where genetic factors are stronger, and adult forms where genetic influences are less strong and obesity, pregnancy, infection, myocardial infarction and other stress may act as precipatating factors. Simpson (1964) and Falconer (1965) have given support to this multifactorial mode of transmission which supposes all individuals to have an underlying graded attribute to diabetes called liability. Total liability (Falconer, 1965) includes both a given individual's additive genetic predisposition (heritability of liability) of the diabetic trait and the sum of the nongenetic or environmental influences, the curve having a normal unimodal distribution in the general population. The point on this continuous scale of liability at which the disease becomes manifest as overt diabetes is termed the 'threshold', and in the families of diabetics this curve would be shifted to the right.
Estimates of heritability can be derived given the proportion of affected persons in the general population and in various categories of relatives of affected persons (Falconer, 1965) . Thus the heritability of liability to diabetes as analysed from sib correlation decreases with increasing age and is estimated at 65 to 75 per cent in people 340 below the age of 30 years but 25 to 40 per cent in people over the age of 50 years.
INSULIN SYNTHESIS
The structure of insulin in terms of its amino-acid sequence and A and B chains was established in 1955 (Sanger et al., 1955) , with a molecular weight about 5,700, and though subject to species variation involving about one to four amino-acids, the total number remains constant at 51. Biosynthesis follows the general principles for protein synthesis, taking place on the ribosomes of the endoplasmic reticulum in a linear fashion and directed by messenger RNA. Transfer from the endoplasmic reticulum to the Golgi apparatus occurs where the insulin is packaged into membrane lined beta granules (Renold, 1970) . Laboratory synthesis has been achieved independently in the USA (Katsoyannis et al., 1964) , Germany (Zahn et al., 1965) and China (Kung et al., 1966) .
Pro-insulin
Earlier studies suggesting that the A and B chains might by synthesised separately have been revised with the recent finding of a single chain precursor, pro-insulin (Steiner et al., 1967) of molecular weight 9,000. This was first isolated from human islet tumour and later of islets from normal man and other species. Conversion into insulin takes place by removal of a connecting peptide (C-peptide) of about 30 amino-acids by a peptidase present both in the beta cells and plasma.
Pro-insulin though having a high degree of crossreactivity in the insulin immunoassay probably has only low biological activity as determined by its effect on blood glucose, muscle and fat cells. There is no evidence that pro-insulin is secreted into the circulation in increased amounts in genetic diabetes and recent estimates show that it represents less than 15 per cent of plasma immuno-reactive insulin (Goldsmith et al., 1969). Insulin itself is degraded by cleavage of the inter-chain disu1phide bonds into separate A and B chains, of low biological activity under the influence of glutathione-insulin transhydrogenase (GIT) (Tomizawa & Halsey, 1969) , and both chains can be measured by immunoassay (Meek et al., 1968 ). This enzyme is present mainly in the liver, though a similar if not identical enzyme is present in other tissues, including the renal tubules.
Genetic influences, as already discussed, could theoretically operate at several levels and might affect, for instance, pro-insulin synthesis, conversion of pro-insulin to insulin, or cleavage of insulin. Despite isolated reports there is still no good evidence of abnormal biosynthesis of insulin (Levine, 1967) or of altered GIT activity in diabetes (Berson & Yalow, 1964) .
INSULIN STORAGE AND RELEASE
Insulin is stored as relatively insoluble complexes with zinc and protein in the granules and cytoplasm of the beta cells. This is normally an efficient mechanism, preventing spontaneous hypoglycaemia, and is probably defective in islet adenomata (Marks & Rose, 1965) . Insulin release follows the appropriate stimulus, when the storage granules migrate to the cell surface by a process known as emiocytosis (Lacy & Hartroft, 1959) with fusion of the granule and cell membranes and final release of their products. The morphological aspects and complexities of insulin release have been recently reveiwed (Renold, 1970) . The secretion of insulin is probably biphasic, an initial rapid transient secretory response representing release from stored insulin is followed by a more sustained phase, probably partly coupled to the stimulation of the synthetic mechanism, and represents a two pool model rather than any feedback inhibition of insulin release by high local insulin concentration (Grodsky et al., 1968 ).
An increasing, and somewhat bewildering number of factors regulating insulin release have been recognised in recent years. Their relative importance and interdependence are the subject of intensive study and have been reviewed in detail (Mayhew et al., 1969) .
Glucose
Glucose remains the major physiological and most potent stimulus for insulin release in man. The precise mechanism of glucose stimulated insulin release is still not elucidated and is probably complex. Phosphorylation is essential (Malaisse et al., 1968 ) and the glucose-6-phosphate is probably metabolized The Pathogenesis of Diabetes Mellitus beyond this via the pentose phosphate pathway to a 5-C metabolite, in order to stimulate the insulin secretory mechanism (Montague & Taylor, 1968 ). Enteric hormones The greater insulin secretory response observed following glucose administration via the oral or intraduodenal route compared with a similar load given via the intravenous route, even despite the higher blood glucose levels associated with the latter (Perley & Kipnis, 1963) is probably due to the release of one or more of the intestinal hormones (Dupre, 1964) . Gastrin, secretin, pancreozymin and enteroglucagon have all been shown to have insulin releasing activity in vivo and in vitro though the results of some of these studies are conflicting (Lazarus et al., 1968) . Enteroglucagon probably consists of at least two components of jejunal origin both of which crossreact immunologically with pancreatic glucagon and stimulate insulin release. One, of larger molecular weight than pancreatic glucagon has no glycogenolytichyperglycaemic action and the other which has an identical molecular weight to pancreatic glucagon has a glycogenolytic effect (Unger et al., 1968) .
The physiological role of the enteric hormones has not been clearly defined but it seems that following the ingestion of food they may provide the initial stimulus to insulin release preceding alimentary hyperglycaemia, thereby promoting more effective utilization and storage of nutrients, especially by the liver.
Amino-acids
In certain species, especially fish, aminoacids are the major stimulus to insulin secretion and this alternative physiological mechanism still survives in the mammalian islets. Oral or intraduodenal essential aminoacids given as mixtures or individually, in the absence of glucose, stimulate insulin release (Floyd et al., 1966) , and certain amino-acids may also directly stimulate insulin release in vitro (Edgar et al., 1969) . The potency of the individual amino-acids varies, arginine, lysine, phenylalamine, and leucine being the most potent in this order. The mechanism of the amino-acid stimulated insulin release is not known though they have been thought to enhance the insulin secretory effect of glucose metabolites within the beta cell (Edgar et 01., 1969) . They may also act via the enteric hormones secretin and pancreozymin which are both secreted in response to protein foods (Jarrett et 01., 1969) . The released insulin itself plays an important role in protein metabolism stimulating the incorporation of amino-acids in protein (Lukens, 1964) .
Inorganic ions
The importance of inorganic cations in insulin release has been demonstrated by in vitro studies. Calcium ion, though not effective by itself in producing insulin secretion seems essential for both glucose and tolbutamide stimulated insulin release (Curry et 01., 1968) . The presence of magnesium ions does not appear to be necessary providing calcium is already present (Grodsky & Bennett, 1966) . The relative concentration of other cations including potassium, and sodium and potassium probably modifies insulin release (Milner & Hales, 1968 ). The precise level of these cationic effects on insulin release is not known, but is presumably mediated by an alteration of membrane potential (Mayhew et 01., 1969; Renold, 1970) . Endocrine regulation The enteric group of hormones including enteroglucagon and their role in triggering insulin release following the ingestion of glucose and amino-acids has already been discussed.
Pancreatic glucagon. Pancreatic glucagon now appears to have an apparent conflicting double role. The effect on glucose homeostasis has been well documented, whereby during acute hypoglycaemic states it provides glucose by stimulating increased hepatic glycogenolysis. It has been shown more recently that pancreatic glucagon, in the absence of any change in blood glucose, is a potent stimulator of insulin release in man in vivo (Samols et 01., 1965, and others) and in vitro (Turner & McIntyre, 1966 and others) . Pancreatic glucagon is itself released by pancreozymin, intraduodenally or intravenously administered amino-acids but not by glucose 342 (Lawrence, 1969) . Glucagon may thus have a physiological role in insulin release following predominantly protein meals to prevent hypoglycaemia which might otherwise follow the protein-stimulated insulin release. These complex inter-relationships have been reviewed by Buchanan (1969) and Lawrence (1969) .
Adrenergic receptors. Catecholamines, adrenaline particularly and noradrenaline to a lesser extent exert a direct inhibitory effect on glucose stimulated insulin release from beta cells in vivo (Kosaka et 01., 1964) and in vitro (Malaisse et 01., 1967) , and can thus produce hyperglycaemia independent of their effect on increased hepatic glycogenolysis. Porte et 01., 1966 were the first to show that the insulin suppressing effect of catecholamines was mediated by the oc adrenergic receptors. ,B-receptor blockade usually inhibited and oc-receptor blockade enhanced glucose induced insulin release in vivo (Porte, 19670; Cerasi et 01., 1969) and in vitro (Malaisse et 01., 19670) . Beta adrenergic receptors probably participate in the physiological stimulation of insulin release acting via the adenyl cyclase system (Porte, 1967b) with which the receptors are probably closely associated (Robison et 01., 1967) , and stimulation augments the intracellular accumulation of cyclic 3'5' AMP.
Cyclic 3' S' adenosine monophosphate. Many of the hormones causing insulin release (glucagon, gastrin, ACTH, TSH) and agents causing ,B-adrenergic receptor stimulation probably do so by the mechanism of adenyl cyclase stimulation. The enzyme adenyl cyclase is situated in the cell membrane and catalyses the formation of intracellular cyclic 3'5' AMP from adenosine triphosphate. Cyclic 3'5' AMP itself has been shown to stimulate insulin secretion in vitro (Sussman & Vaughan, 1967) . Insulin release correlates accurately with pancreatic islet concentration of the cyclic nucleotide (Turtle & Kipnis 19670) . Intracellular levels of cyclic 3'5' AMP may be increased not only by hormones or substances which activate adenyl cyclase but also by agents such as caffeine or theophylline which competitively inhibit the specific enzyme 3'5' cyclic nucleotide phosphodiesterase (Turtle et al., 1967) which normally hydrolyses cyclic 3'5' AMP to 5' AMP. The link between increased cellular concentration of cyclic 3'5' AMP and insulin release is not yet elucidated but Malaisse et 01. (1967b) have suggested that cyclic 3'5' AMP may activate glycogen phosphorylase in the beta cells.
In summary, evidence from several sources suggests that glucose mediated insulin release involves a complex multicomponent system possibly including a 5-carbon metabolite of glucose, intracellular cyclic 3'5' AMP levels, ocand ,8-adrenergic receptors and Ca++ ions.
PLASMA INSULIN RESPONSE TO GLUCOSE
The development of a sensitive and specific radioimmunoassay of insulin by Yalow and Berson (1960) and subsequent modifications (Hales & Randle, 19630;  Morgan & Lazarow, 1963 and others), unlike the former bioassay procedures, made the accurate measurement of plasma insulin possible. Studies during the last 10 years have led to considerable insight into the patterns of insulin secretion under various physiological and pathological conditions. The insulin secretory pattern in response to glucose loading has been extensively investigated and fairly well established for normal persons, genetic diabetics and those predisposed to diabetes. In normal persons, following glucose loading there is a prompt release of insulin which reaches its peak in 30 to 60 minutes and returns to normal in about 2 hours (Yalow & Berson, 1960; Hales & Randle, 1963b; Welborn et 01., 1966) , the blood glucose and insulin curves remaining in phase. In maturity-onset (insulin independent) diabetics there is an abnormal and characteristic delay of insulin secretion which does not reach its maximum before 60 minutes (Yalow & Berson, 1960; Perley & Kipnis, 19660, and others), and which may continue for some 3 or 4 hours despite a return of the blood glucose to low levels, occasionally resulting in symptomatic hypoglycaemia. In some, the insulin secretion, though delayed, is greater than normal and earlier workers took this to be evidence of increased peripheral insulin antagonism. This hyperinsulinaemia is only relative, and during the first 3 hours is less than would be expected from the blood glucose concentration (Perley & Kipnis, 19660;  Seltzer et 01.,
The Pathogenesis of Diabetes Mellitus 1967) as can be shown by the 'insulinogenic index' of Seltzer (Seltzer & Harris, 1964) which is derived from measurement of the areas under the blood glucose and insulin curves. The majority of insulin independent diabetics probably have a low insulin response to glucose (McKiddie et 01., 1969) , and the height of the response would appear to be inversely proportional to the severity of the carbohydrate intolerance (Bagdade et 01., 1967; McKiddie et 01., 1969) . In juvenileonset (insulin dependent) diabetics where there is the most severe degree of carbohydrate intolerance there is little or no fasting insulin and following glucose the plasma insulin response is either inappropriately low or may not be detectable, representing a total failure of beta cell function.
A similar delayed and diminished insulin releasing capacity of the beta cells in diabetics has been shown to follow tolbutamide (Perley & Kipnis, 19660) and amino-acid administration (Fajans et 01., 1969) . Studies in close relatives of diabetics with normal standard carbohydrate tolerance likewise reveal the delayed and subnormal insulin response to glucose as has been shown in the yet unaffected partners of diabetic monozygotic twins (Cerasi & Luft, 1967; Pyke & Taylor, 1967) and in children having at least one first degree relative with diabetes (Cerasi & Luft, 1970) .
The evidence to date would suggest that the essential feature of genetic diabetes is a characteristic delayed and subnormal insulin secretion in response to hyperglycaemia and other stimuli. This is probably a common factor at all stages from pre-diabetes to overt diabetes, and is present from infancy, as a result of a genetically determined defect (s) of the beta cells.
FORMS OF PLASMA INSULIN
'Free' and 'Bound' insulin This difficult subject is still somewhat confused though it would appear that insulin probably exists in the plasma in two main physical forms. Firstly, in the form it is released from the pancreas into the portal circulation in which it is loosely bound to albumin and known as 'free' insulin (Antoniades et 01., 1961) . This has normal biological activity in muscle and adipose tissue and corresponds to immunoreactive insulin (IRI) as detected by immunoassay. Biological activity is completely inhibited by the addition of insulin antibody (anti-insulin serum) and there is evidence to suggest that this form plays the major role in the regulation of the blood glucose level.
A portion of this free insulin is bound in an as yet unknown manner, probably in the liver, resulting in the second main physical form of insulin, which has been called 'bound' or 'complexed' insulin (Antoniades et aZ., 1961) . This migrates mainly with f3 globulin, has full biological activity, but is not revealed by immunoassay. The addition of antiinsulin serum results in only partial inhibition of its biological activity. In nondiabetics the ratio of free to bound insulin varies according to the metabolic state most of the insulin being in the bound form during fasting, with a decrease following carbohydrate feeding or intravenous glucose, when it is suggested a dissociation of free insulin from the complex takes place (Antoniades et al., 1962) . In diabetics most of the insulin exists in the bound form despite hyperglycaemia but claims that one of the defects in diabetes might be an increase in insulin binding, or alternatively an abnormality in the insulin dissociation mechanism (Antoniades et aZ., 1962), have not been substantiated.
Insulin-like activity (ILA) Using the same plasma sample, the amount of insulin detected by the rat diaphragm or rat epididymal fat pad bioassay procedures is considerably greater than that measured by the radioimmunoassay, and the insulin level measured by the former methods has accordingly been termed 'insulin-like activity' (ILA). ILA can be separated in various ways, including the addition of anti-insulin serum, extraction with acid ethanol, treatment with cation excharge resin and electrophoresis. The addition of anti-insulin serum does not lead to a suppression of all of its biological activity, the portion that is inhibited is called 'suppressible ILA' and the remaining portion 'non-suppressible ILA' (NSILA) (Froesch et aZ., 1963) . Suppressible ILA and plasma insulin measured by immunoassay 344 from the same sample show identical values. Similar findings were reported by Samaan et aZ. (1963) who designated the ILA of normal serum inhibited by antiserum as 'typical' and the remaining non-inhibited portion as 'atypical ILA'. Non-suppressible ILA though having similar biological activity to immunoreactive insulin both in vivo and in vitro has different physiochemical properties with a variable MW 70,000 to 150,000 depending on the pH and migrates with the OC 2 and f3 globulins on electrophoresis.
Whether non-suppressible ILA is formed in the liver and whether it is derived from insulin itself or other plasma factors is still not certain. The evidence from various species is conflicting but on balance intact beta cells are probably necessary for nonsuppressible ILA production. In normal individuals non-suppressible ILA in plasma is unchanged after intravenous or oral glucose (Lynsgoe, 1967) and so far it is not known whether it plays any part in the normal regulation of blood sugar.
'Bound insulin', atypical insulin and nonsuppressible ILA probably represent the same material (Poffenburger et aZ., 1968) .
INSULIN ANTAGONISM
Though there is considerable evidence at present to support the view that the major defect in genetic diabetes involves an abnormal secretory response of the beta cells to glucose, increased insulin antagonism cannot be completely excluded as a contributory aetiological factor. Such possible causes have included a primary disturbance in fatty acid metabolism (Hales & Randle, 1963b) with an increased release of fatty acids from adipose tissue resulting in insulin antagonism, the synalbumin insulin antagonism described by Vallance-Owen et aZ. (1955) , together with the antagonism associated with obesity, pregnancy and certain endocrine disorders. Synalbumin antagonism Since 1955 Vallance-Owen and his coworkers (Vallance-Owen et aZ., 1955) have developed an hypothesis that a pituitaryadrenal dependent and genetically determined antagonist, normally present in plasma and associated with the albumin fraction, is increased in diabetics and their relatives. Up to 20 to 25 per cent of the population are postulated to carry this trait which is inherited as a Mendelian dominant. This material antagonises the effect of insulin on the uptake of glucose by the rat hemidiaphragm. It was later suggested that the substance was B chain connected to albumin (Ensinck & Vallance-Owen, 1963) . Others have failed to confirm this hypothesis (Berson & Yalow, 1965; Cameron et al., 1964) . In vivo administration of the substance does not produce impaired glucose tolerance (Davidson & Godner, 1967) and the aetiological role of this antagonist must therefore remain in doubt.
Obesity
Obesity which commonly coexists with diabetes and accounts for a large proportion of the insulin independent population has been long known to be associated with increased resistance to insulin in the peripheral tissues.
The nature of this insulin antagonism is still not clear, but it may be due to increased rates of fatty acid oxidation. The insulin secretory response, in obesity uncomplicated by diabetes, confirms this increased antagonism with raised fasting insulin levels, and an excessive, but prompt rise following oral glucose, usually with the preservation of normal carbohydrate tolerance (Perley & Kipnis, 1965) . This defect is probably not primary and similar raised insulin levels are seen in experimental animals made obese (Hales & Kennedy, 1964) . The insulin response represents the compensation of the normal pancreas to peripheral insulin antagonism and tends to return to normal following weight loss (Yalow & Berson, 1965) , and starvation (Solomon et al., 1968) .
When mild diabetes accompanies obesity the insulin secretory response following glucose is more typically the impaired type seen in non-obese diabetics with characteristic delayed initial secretion, and the plasma insulin levels though raised represent inappropriate secretion in relation to the blood glucose levels, and not the true insulin hyperresponsiveness seen in obese nondiabetic subjects (Luft et al., 1968) . This and other The Pathogenesis of Diabetes Mellitus observations lend support to the view that the insulin resistance associated with obesity precipitates diabetes only in subjects with pre-existing impairment of the insulin secretory response of the islets (Luft et al., 1968) .
Pregnancy
Normal pregnancy, especially during the second and third trimesters is diabetogenic and like obesity is associated with increased insulin antagonism which aggravates any pre-existing diabetic tendency in genetically predisposed women (Kalkhoff et al., 1964) . Glucose loading is followed by an excessive insulin response in order to keep the blood glucose normal, and this promptly returns to normal following pregnancy. Though increased oestrogen and progesterone levels may contribute, the insulin resistance is probably mainly due to the release of placental lactogen (Josimovich & Maclaren, 1962) , a growth hormone-like polypeptide with similar immunological and biological effects, which has been shown to accelerate lipolysis in adipose tissue (Turtle & Kipnis, 1967b) . Genetically predisposed women, who develop diabetes during pregnancy (gestational diabetes) may return to normal carbohydrate tolerance following pregnancy only to become permanently diabetic in later years. Increasing parity may contribute to this (Pyke, 1956) . Other Endocrine influences. The association between diabetes and acromegaly is well known. Young (1937) showed that administration of anterior pituitary extract could produce permanent diabetes in dogs. Karam et al. (1965) and others have noted high insulin levels in active acromegalies but not in the inactive disease. Though administration of growth hormone to man or experimental animals leads to increased i.nsulin levels following glucose or tolbutamide, there is no evidence from in vitro studies that growth hormone has a direct effect on insulin release from the islets (Mayhew et al., 1969) . The mechanism of increased insulin release is not clear and may be due to a direct effect of growth hormone on adipose tissue leading to excessive lipolysis and increased insulin antagonism, or the hormone may cause an adjustment of the homeostatic control of the pancreatic islets with increased insulin release at any particular level of glucose (Mayhew et al., 1969) . There is no evidence that growth hormone plays any primary aetiologica1 role in genetic diabetes, untreated diabetics at diagnosis having growth hormone levels within the normal range (Hunter et al., 1966) . Of the 25 per cent of acromegalies who develop frank diabetes it is believed that this is more likely in those with a positive family history (Luft et al., 1967) .
Excess glucocorticoid secretion, as is seen in patients with Cushing's syndrome, and in patients receiving corticosteroid therapy, is accompanied by an elevated plasma insulin response following glucose or tolbutamide (Perley & Kipnis, 1966b) . Glucocorticoids probably increase insulin resistance byaccelerating gluconeogenesis and increased circulating plasma free fatty acid levels and unlike ACTH do not have a direct effect on insulin release. Studies by McKiddie et al. (1968) have suggested that long-term corticosteroid therapy produces abnormal glucose tolerance only in those with the diabetic trait.
Primary aldosteronism may be associated with abnormal carbohydrate tolerance and mild diabetes and it is thought that the hypokalaemia leads to impaired insulin release (Conn, 1964) .
Thyroxine, like growth hormone and glucocorticoids, has no direct stimulatory effect on insulin release but in excess may likewise lead to impaired carbohydrate tolerance. Though the mechanisms have not been fully established these hormones modify the responsiveness of the islets to glucose. Where abnormal carbohydrate tolerance or frank diabetes occurs in the presence of excess of these hormones there may be an underlying genetic susceptibility to diabetes.
Catecholamines
Diabetes mellitus may be seen in 10 per cent of cases of phaeochromocytoma (Freedman et al., 1958) , and temporary impaired carbohydrate tolerance may occur in conditions leading to increased catecholamine release such as bums, surgery and cardiogenic shock (MacKenzie et al., 1964; Allison et al., 1967) . In the latter condition hypoxia (Baum & Porte, 1969), hypothermia (Blackard et al., 346 1969) and impaired pancreatic circulation (Bauer et al., 1969) may also contribute to the impaired insulin release, though plasma insulin may be elevated in the early stages of hypovolaemic shock (Bauer et al., 1969) .
The effect of the catecho1amines is due not only to their powerful stimulatory effect on hepatic glycogenolysis and lipolysis in adipose tissue leading to excessive insulin antagonism, but also to a direct inhibitory effect of glucose mediated insulin release, by stimulation of the a: adrenergic receptors in the islets as has already been discussed.
Other aetio1ogical factors Mumps is occasionally associated with diabetes of acute onset in man and certain varieties of viruses have been reported to damage beta cells in animals. Gamble and Taylor (1969) have claimed a seasonal incidence in the onset of insulin dependent diabetes in young patients as possible evidence of an infective factor, and have shown a significant positive correlation with the annual prevalence of Coxsachie virus type B4. This interesting possibility awaits further investigation.
Though there is an association between insulin dependent diabetes and organ-specific autoimmune disease, especially in respect of an increased prevalence of antibodies to thyroid cell cytoplasm and gastric parietal cell cytoplasm in diabetics (Irvine et al., 1970) there is no good evidence of autoantibodies to insulin or other constituents of the beta cells in untreated diabetes (Deckert, 1967) or that autoimmunity plays a causative role in diabetes mellitus.
